Apply to trial NCT06850571

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 4Drug trial

Aflibercept and Bevacizumab for Diabetic Maculopathies

The goal of this clinical trial is to to evaluate the clinical outcomes following treatment with bevacizumab versus aflibercept. These outcomes include: * Functional changes: The visual outcomes achieved by testing visual acuity * Anatomical changes: macular thickness and edema by optical coherence tomography (OCT).

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Aflibercept and Bevacizumab for Diabetic Maculopathies

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening